Author: Drug Science

Speakers: Dr Leon Barron Dr Barron a GP based in London, with interests in mental health and managing complex symptoms that often combine physical, psychological and social components. He is Founder of The Primary Care Cannabis Network which provides an independent, educational platform for GPs. He is also an executive committee member of The Medical Cannabis Clinicians Society. Alkyoni Anthanasiou-Fragkouli Alkyoni is a medical cannabis and psychedelics researcher at Drug Science working in the burgeoning psychedelic sector. She Manages T21, which is the biggest medical cannabis study in the UK hoping to provide evidence for the NHS to gain funding…

Prof David Nutt presents a talk followed by Q&A on cannabis, exploring its history, political context, what we are learning about cannabis-based medicines and how they can be accessed in the UK. He includes some of our latest data from T21, Drug Science’s medical cannabis registry – the largest study of its kind in Europe – looking at how medical cannabis is proving effective for helping with general health, mood and sleep, anxiety, PTSD and chronic pain. source

Please like and share this video and promote Project Twenty21 to help more patients like Rosie access affordable medical cannabis and provide evidence for it to be available on the NHS. JOIN PROJECT TWENTY21 https://www.drugscience.org.uk/twenty21/ If you want to help support access to life-changing medicines, please consider a donation to Drug Science. Every donation helps patients like Rosie, and countless more if we can make medical cannabis available on the NHS! 🙏 DONATE HERE https://www.drugscience.org.uk/support-drug-science/ JOIN OUR MAILING LIST Get notified about new research and events featuring early results so you can stay ahead of psychedelic research and drug policy…